Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000216174 | SCV000275966 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000444871 | SCV000531187 | likely benign | not specified | 2018-01-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000216174 | SCV000911527 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000444871 | SCV000919057 | likely benign | not specified | 2019-08-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000917930 | SCV001063224 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004791340 | SCV005406384 | benign | Familial cancer of breast | 2024-09-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |